A detailed history of Integral Health Asset Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 50,000 shares of NTRA stock, worth $5.33 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
50,000
Previous 225,000 77.78%
Holding current value
$5.33 Million
Previous $14.1 Million 67.55%
% of portfolio
0.43%
Previous 1.92%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $10.4 Million - $16.3 Million
-175,000 Reduced 77.78%
50,000 $4.57 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $938,749 - $1.57 Million
25,000 Added 12.5%
225,000 $14.1 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $8.68 Million - $12.5 Million
200,000 New
200,000 $8.85 Million
Q1 2023

May 09, 2023

SELL
$36.57 - $58.29 $438,840 - $699,480
-12,000 Reduced 13.79%
75,000 $4.16 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $2.97 Million - $4.17 Million
87,000 New
87,000 $3.49 Million
Q4 2021

Feb 02, 2022

SELL
$86.26 - $119.0 $3.45 Million - $4.76 Million
-40,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $1.5 Million - $1.9 Million
-15,000 Reduced 27.27%
40,000 $4.46 Million
Q2 2021

Aug 30, 2021

SELL
$86.05 - $119.72 $4.73 Million - $6.58 Million
-55,000 Reduced 50.0%
55,000 $6.24 Million
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $6.45 Million - $8.98 Million
75,000 Added 214.29%
110,000 $12.5 Million
Q1 2021

May 10, 2021

SELL
$91.47 - $124.36 $914,700 - $1.24 Million
-10,000 Reduced 22.22%
35,000 $3.55 Million
Q4 2020

Feb 16, 2021

SELL
$66.66 - $111.74 $1.4 Million - $2.35 Million
-21,000 Reduced 31.82%
45,000 $4.48 Million
Q3 2020

Nov 16, 2020

BUY
$45.89 - $72.67 $3.03 Million - $4.8 Million
66,000 New
66,000 $4.77 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.